Clinical Trial: SOM230 Ectopic ACTH-producing Tumors

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: A Proof of Concept and Open-label Study to Test the Efficacy and Safety of Pasireotide in Patients With Ectopic ACTH-producing Tumors

Brief Summary: The purpose of this prospective open-label phase II study, is to evaluate the efficacy of pasireotide twice daily subcutaneous injections for normalizing 24 hour urine free cortisol in patients with ectopic ACTH-producing tumors as measured by the proportion of patients achieving normal UFC at the end of the study period.